NDC 42367-570

VASOPRESSIN

Vasopressin

VASOPRESSIN is a Parenteral Injection in the Human Prescription Drug category. It is labeled and distributed by Eagle Pharmaceuticals, Inc.. The primary component is Vasopressin.

Product ID42367-570_a9a870ba-7385-4c75-a5ab-a995ecb12750
NDC42367-570
Product TypeHuman Prescription Drug
Proprietary NameVASOPRESSIN
Generic NameVasopressin
Dosage FormInjection
Route of AdministrationPARENTERAL
Marketing Start Date2022-01-10
Marketing CategoryANDA /
Application NumberANDA211538
Labeler NameEagle Pharmaceuticals, Inc.
Substance NameVASOPRESSIN
Active Ingredient Strength20 U/mL
Pharm ClassesVasopressins [CS],Vasoconstriction [PE],Decreased Diuresis [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 42367-570-87

25 VIAL, MULTI-DOSE in 1 CARTON (42367-570-87) > 1 mL in 1 VIAL, MULTI-DOSE (42367-570-22)
Marketing Start Date2022-01-10
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "VASOPRESSIN" or generic name "Vasopressin"

NDCBrand NameGeneric Name
42367-570VASOPRESSINVASOPRESSIN
51662-1314VASOPRESSINVASOPRESSIN
52584-302VASOPRESSINvasopressin
63323-302VasopressinVASOPRESSIN
42023-164VasostrictVasopressin
42023-190VasostrictVasopressin
42023-219VasostrictVasopressin
42023-220VasostrictVasopressin
42023-237VasostrictVasopressin
71872-7014VasostrictVasopressin
71872-7264VasostrictVasopressin

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.